Search results
India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says
Reuters via Yahoo Finance· 5 days ago...HYDERABAD/BENGALURU (Reuters) -Cipla is open to partnering with U.S. drugmaker Eli Lilly to market its blockbuster obesity treatment drugs in India, the company's CEO said on Friday. ...Sensing the market opportunity, Indian drugmakers, including Cipla, are working to develop their copycat...
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows By Reuters
Investing.com· 5 days agoThe data also showed that 6% of those polled said they were currently using a GLP-1 drug, such as...
Is Eli Lilly Stock A Better Pick Over Amgen?
Forbes· 2 days agoAlso, Eli Lilly has seen a better revenue growth and is more profitable. There is more to the comparison, and in the sections below, we discuss why we...
Healthy Returns: 1 in 8 adults have taken Ozempic or other GLP-1s, survey says
CNBC· 12 hours agoThe use of a buzzy class of weight loss and diabetes medications is more common than ever. About 1 in 8 adults in the U.S. has used a GLP-1 drug ...
Innovent’s mazdutide superior to Trulicity in Phase III T2D trial
Clinical Trials Arena via Yahoo Finance· 5 days agoThe...Trulicity for glycaemic control, as well as showing multiple cardiometabolic benefits...
New Weight-Loss, Diabetes Drugs Reach One in Eight Americans
Bloomberg· 5 days agoOne in eight US adults has tried medications from the fast-growing class of new diabetes and obesity...
One in eight U.S. adults have taken Ozempic or similar weight loss drugs
Dallas Morning News· 5 days agoOne in eight US adults has tried medications from the fast-growing class of new diabetes and obesity...
Obesity drug slashes risk of heart attack or stroke 'regardless of weight lost’
BioPharma-Reporter· 17 hours agoA five-year trial investigated whether semaglutide, a drug currently sold under the brand names...
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows
Reuters· 5 days agoAbout one in eight adults have taken a drug belonging to the GLP-1 class of medications for weight ...
What the results of Wegovy’s longest clinical trial yet show about weight loss, side effects and...
CNN.com· 1 day agoNew analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on...